Philippines - English - FDA (Food And Drug Administration)

cyno sure healthcare inc - clotrimazole - tablet, vaginal - 100mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

deeplaid pharmaco ltd. (homoeo) - cynodon (durba) - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

s.b. homoeo laboratory - cynodon (durba) - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

the homoeo research laboratory (bd) ltd. - cynodon (durba) - liquid

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10) - cynodon dactylon pollen 10000 [bau] in 1 ml - indicated use of allergenic extracts is for the diagnosis and treatment (hyposensitization therapy) of patients who experience allergic symptoms due to exposure to grass pollen and who exhibit type i skin sensitivity when tested to those specific allergens. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants in situations where the offending allergen cannot be avoided. for previously untreated patients, prior to the initiation of therapy, clinical sensitivity to the standardized grass pollen extract should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. 10,000 bau/ml extracts are indicated for percutaneous testing. if negative, the 100,000 bau/ml dose may be used. availability of 10,000 and 100,000 bau/ml dosages facilitate safe

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), carya illinoinensis pollen (unii: pyo4jr720y) (carya illinoinensis pollen - unii:pyo4jr720y), carya tomentosa pollen (unii: g2a764t54b) (carya tomentosa pollen - unii:g2a764t54b), amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), rumex acetosella pollen (unii: n52miq - cynodon dactylon pollen 16 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10) - cynodon dactylon pollen 10000 [bau] in 1 ml - indications and usage     allergenic extract is indicated for diagnostic testing and treatment (immunotherapy) of patients whose histories indicate allergic symptoms upon natural exposure to grass allergens. confirmation is determined by skin testing. 10,000 bau/ml extracts are intended for percutaneous testing. if negative, 100,000 bau/ml products can be used for percutaneous test. dilutions made from 10,000 bau/ml products are indicated for immunotherapy of previously untreated patients. if 10,000 bau/ml product is tolerated and symptoms persist, dilutions made from 100,000 bau/ml can be administered. standardized grass pollen extracts labeled in bioequivalent allergy units (bau/ml) are not interchangeable with grass pollen extracts labeled in allergy units (au/ml) or with non-standardized grass pollen extracts. contraindications     do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of underly

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cynodon dactylon) pollen 100dbu/ml solution for skin prick test (lofarma - bermuda grass (cynodon dactylon) pollen allergen extract - solution for skin-prick test

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cynodon dactylon) pollen 10,000du/ml solution for skin prick test (allergy therapeutics (uk) ltd - bermuda grass (cynodon dactylon) pollen allergen extract - solution for skin-prick test

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cynodon dactylon) pollen 50hep/ml solution for skin prick test (inmunotek - bermuda grass (cynodon dactylon) pollen allergen extract - solution for skin-prick test